Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt No Debt
PURE's Cash to Debt is ranked higher than
99% of the 1021 Companies
in the Global Chemicals industry.

( Industry Median: 0.62 vs. PURE: No Debt )
PURE' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: No Debt

Equity to Asset 0.53
PURE's Equity to Asset is ranked higher than
63% of the 1017 Companies
in the Global Chemicals industry.

( Industry Median: 0.52 vs. PURE: 0.53 )
PURE' s 10-Year Equity to Asset Range
Min: -0.48   Max: 0.98
Current: 0.53

-0.48
0.98
F-Score: 3
Z-Score: -43.09
M-Score: -9.00
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -895.00
PURE's Operating margin (%) is ranked lower than
67% of the 1010 Companies
in the Global Chemicals industry.

( Industry Median: 5.85 vs. PURE: -895.00 )
PURE' s 10-Year Operating margin (%) Range
Min: -1930.13   Max: 8.82
Current: -895

-1930.13
8.82
Net-margin (%) -935.49
PURE's Net-margin (%) is ranked lower than
68% of the 1011 Companies
in the Global Chemicals industry.

( Industry Median: 3.81 vs. PURE: -935.49 )
PURE' s 10-Year Net-margin (%) Range
Min: -1841.5   Max: 544.87
Current: -935.49

-1841.5
544.87
ROA (%) -372.02
PURE's ROA (%) is ranked lower than
68% of the 1015 Companies
in the Global Chemicals industry.

( Industry Median: 3.41 vs. PURE: -372.02 )
PURE' s 10-Year ROA (%) Range
Min: -372.02   Max: 25.65
Current: -372.02

-372.02
25.65
ROC (Joel Greenblatt) (%) -5026.71
PURE's ROC (Joel Greenblatt) (%) is ranked lower than
68% of the 1010 Companies
in the Global Chemicals industry.

( Industry Median: 11.13 vs. PURE: -5026.71 )
PURE' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -5026.71   Max: 13.64
Current: -5026.71

-5026.71
13.64
Revenue Growth (%) -37.60
PURE's Revenue Growth (%) is ranked lower than
63% of the 882 Companies
in the Global Chemicals industry.

( Industry Median: 4.30 vs. PURE: -37.60 )
PURE' s 10-Year Revenue Growth (%) Range
Min: -71.2   Max: 75.2
Current: -37.6

-71.2
75.2
EBITDA Growth (%) -24.20
PURE's EBITDA Growth (%) is ranked lower than
58% of the 802 Companies
in the Global Chemicals industry.

( Industry Median: 1.90 vs. PURE: -24.20 )
PURE' s 10-Year EBITDA Growth (%) Range
Min: -24.2   Max: 11.6
Current: -24.2

-24.2
11.6
EPS Growth (%) -23.20
PURE's EPS Growth (%) is ranked lower than
51% of the 722 Companies
in the Global Chemicals industry.

( Industry Median: 1.70 vs. PURE: -23.20 )
PURE' s 10-Year EPS Growth (%) Range
Min: -23.2   Max: 8.1
Current: -23.2

-23.2
8.1
» PURE's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with PURE

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 21.40
PURE's P/B is ranked lower than
73% of the 1050 Companies
in the Global Chemicals industry.

( Industry Median: 1.86 vs. PURE: 21.40 )
PURE' s 10-Year P/B Range
Min: 2.16   Max: 149
Current: 21.4

2.16
149
P/S 26.80
PURE's P/S is ranked lower than
76% of the 1050 Companies
in the Global Chemicals industry.

( Industry Median: 1.02 vs. PURE: 26.80 )
PURE' s 10-Year P/S Range
Min: 3.02   Max: 520
Current: 26.8

3.02
520
EV-to-EBIT -2.62
PURE's EV-to-EBIT is ranked lower than
53% of the 1050 Companies
in the Global Chemicals industry.

( Industry Median: 18.25 vs. PURE: -2.62 )
PURE' s 10-Year EV-to-EBIT Range
Min: 9.8   Max: 79.3
Current: -2.62

9.8
79.3
Current Ratio 0.89
PURE's Current Ratio is ranked lower than
62% of the 864 Companies
in the Global Chemicals industry.

( Industry Median: 1.72 vs. PURE: 0.89 )
PURE' s 10-Year Current Ratio Range
Min: 0.15   Max: 31.59
Current: 0.89

0.15
31.59
Quick Ratio 0.56
PURE's Quick Ratio is ranked lower than
64% of the 864 Companies
in the Global Chemicals industry.

( Industry Median: 1.20 vs. PURE: 0.56 )
PURE' s 10-Year Quick Ratio Range
Min: 0.06   Max: 30.75
Current: 0.56

0.06
30.75

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.50
PURE's Price/Median PS Value is ranked higher than
97% of the 1050 Companies
in the Global Chemicals industry.

( Industry Median: 1.13 vs. PURE: 0.50 )
PURE' s 10-Year Price/Median PS Value Range
Min: 0.01   Max: 8.82
Current: 0.5

0.01
8.82
Forward Rate of Return (Yacktman) -120.46
PURE's Forward Rate of Return (Yacktman) is ranked lower than
62% of the 775 Companies
in the Global Chemicals industry.

( Industry Median: 6.73 vs. PURE: -120.46 )
PURE' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -1.5   Max: 65.5
Current: -120.46

-1.5
65.5

Business Description

Industry: Chemicals » Chemicals
Compare:BASFY, DD, SHECY, URALL, APD » details
Pure Bioscience, an early stage Company incorporated in the state of California on August 24, 1992. It has initial public offering in August 1996. The Company is focused on the discovery, development and commercialization of bioscience products that provide solutions to global health challenges. Its technology platform is based on stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial. The Company manufactures and sell SDC-based disinfecting and sanitizing products, which are registered by the Environmental Protection Agency, or EPA, to distributors and end users. It also manufactures and sells various SDC-based formulations to manufacturers for use as a raw material in the production of personal care and other products. The foundation of its technology platform is a proprietary electrochemical process that allows it to generate ionized silver in the presence of organic acid. This process creates a solution containing stabilized ionic silver that can function as an antimicrobial. The Company's current products all contain SDC, which is produced by ionizing silver in citric acid. SDC is non-toxic, non-caustic, colorless, odorless and formulates well with other compounds. The Company believes that SDC is distinguished from other products in the marketplace because of its superior efficacy and toxicity profiles. The Company's manufacture and package its disinfectant and sanitizing products as well as various raw material formulations at its corporate headquarters in El Cajon, California. The Company has previously outsourced some manufacturing and packaging operations to one or more third parties, and may do so in the future where it is economically advantageous; however, it intends to maintain exclusive manufacturing of SDC-based raw material formulations in its facility. The Company's business is subject to various government regulations relating to the protection of public health and the environment.
» More Articles for PURE

Headlines

Articles On GuruFocus.com
PURE Bioscience Reports Operating Results (10-Q) Mar 17 2011 
PURE Bioscience Reports Operating Results (10-Q) Dec 15 2010 
PURE Bioscience (PURE) CFO Andrew J Buckland sells 100,000 Shares Jun 30 2010 
PURE Bioscience Reports Operating Results (10-Q) Mar 12 2009 
PURE Bioscience (PURE) Files Quarterly Report for the Period Ended on 2008-10-31 Dec 15 2008 

More From Other Websites
PURE BIOSCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered... Aug 27 2014
PURE Bioscience to Present at Rodman & Renshaw Annual Global Investment Conference Aug 21 2014
PURE Bioscience Licenses SDC Antimicrobial for Medical Device Disinfectant Use in IVF Market Aug 19 2014
PURE Submits Food Contact Notification to FDA for SDC Antimicrobial Use in Raw Poultry Processing Jul 14 2014
PURE BIOSCIENCE, INC. Financials Jun 17 2014
PURE BIOSCIENCE, INC. Files SEC form 10-Q, Quarterly Report Jun 10 2014
PURE Bioscience Reports Fiscal Third Quarter 2014 Financial Results Jun 10 2014
PURE Creates Market Development Team Focused on Direct Food Contact Application Jun 06 2014
PURE Bioscience to Host Q3 Investor Conference Call June 10th, 2014 and Review Progress of SDC-Based... Jun 03 2014
PURE Bioscience: Patience Is Beginning To Pay Off May 27 2014
PURE Bioscience to Present at LD Micro Invitational on June 4th May 27 2014
PURE Bioscience to Present at Marcum Third Annual Micro Cap Conference May 20 2014
PURE Bioscience Initiates SDC Antimicrobial Testing With Three Additional National QSR Chains May 19 2014
PURE's SDC-Based Antimicrobial Dramatically Reduces Salmonella in Processed Poultry Testing May 01 2014
PURE BIOSCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered... Apr 29 2014
Food Manufacturer and Processor Customers Expand Use of PURE's SDC-Based Hard Surface Disinfectant Apr 15 2014
PURE BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Apr 14 2014
PURE Bioscience Board Reduces to Five Members Apr 14 2014
Quick Service Restaurant Chain Expands Use of PURE Hard Surface Disinfectant Into 650 Stores Apr 09 2014
PURE Bioscience Reports Continued Progress And Leadership Role In 'Preventive' Food Safety Mar 21 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK